COSENTYX® (secukinumab) for injection

COSENTYX® (secukinumab) for injection

Secukinumab is a recombinant human monoclonal IgG1/κ antibody that binds specifically to IL-17A. COSENTYX is a human interleukin-17A antagonist indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis and active ankylosing spondylitis